Related Experiment Video
Updated: Jun 15, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
A fully automatic tool for development of population pharmacokinetic models
Xiaomei Chen1, Rikard Nordgren1, Stella Belin1
1Department of Pharmacy, Uppsala University, Uppsala, Sweden.
A new automatic model development (AMD) tool streamlines population pharmacokinetic (PK) model building. This pharmacometrics software offers a faster, automated approach to creating complex PK models for drug development.
Area of Science:
- Pharmacometrics
- Computational Biology
- Drug Development
Background:
- Population pharmacokinetic (PK) models are crucial for drug development and regulatory evaluation.
- Manual development of PK models is complex, iterative, and time-consuming.
- Existing methods require significant user expertise and effort.
Purpose of the Study:
- To present a novel tool for the fully automatic development (AMD) of population PK models.
- To implement the AMD tool within the open-source Pharmpy library.
- To evaluate the performance and efficiency of the AMD tool.
Main Methods:
- The AMD tool integrates modules for structural, inter-individual variability (IIV), inter-occasional variability (IOV), residual unexplained variability (RUV), covariate, and allometry models.
- Implementation within the Pharmpy open-source library.
- Evaluation using 10 real-world PK datasets, assessing structural, IIV, and RUV models across multiple sequences.
Main Results:
- The AMD tool produced generally consistent structural models across evaluation sequences.
- Final models demonstrated lower Bayesian Information Criterion (BIC) values compared to published models.
- Visual predictive checks indicated comparable model quality, with reasonable run times.
Conclusions:
- The AMD tool is a promising solution for rapid and automated population PK model building.
- It has the potential to enhance the application of modeling and simulation in drug development.
- The tool facilitates efficient PK model development, aiding pharmaceutical companies and regulatory agencies.
More Related Videos
08:43PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis
Published on: May 11, 2017
07:17MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
Published on: February 7, 2025
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...